Abstract:Abstract Background: Oesophageal squamous cell carcinoma (ESCC) is a high malignant cancer, which is the most common subtype of oesophageal cancer. Small nucleolar RNAs (snoRNAs) are a group of novel non-coding RNAs that have been found play a key role in various cancers. Methods: The expression of SNORA42 in ESCC samples and cell lines was measured by using real-time PCR and a series of in vitro and in vivo assays were performed to determine the function of SNORA42 in ESCC. Furthermore, RNA pull-down assay combined with Mass Spectrometry was applied to identify the protein that is associated with SNORA42. Silencing SNORA42 in ESCC cell followed by Next-Generation mRNA Sequencing was used to investigate the signaling pathway regulated by SNORA42. Results: We identified H/ACA box snoRNA42 (SNORA42) wasupregulated in ESCC and had the potential to be applied as a prognostic marker. Specifically, overexpression of SNORA42 promotedESCCprogression in vitro and in vivo , whereas knockdown of SNORA42 had opposite effects. We identified SNORA42 interacted with DHX9, which was up-regulated in ESCC and had a positive correlation with the expression of SNORA42. Furthermore, the promotion of SNORA42 on ESCC phenotypes can be reversed by knockdown of DHX9 . Mechanically, SNORA42 promoted DHX9 expression by attenuating DHX9 transports into cytoplasm, to protect DHX9 from being ubiquitinated and degraded. From KEGG analysis of Next-Generation Sequencing, the NF-κB pathway was one of the most regulated pathways by SNORA42. SNORA42 enhanced phosphorylation of p65 and this effect could be reversed by NF-κB inhibitor, BAY11-7082. Moreover, SNORA42 activated NF-κB signaling through promotingthe transcriptional co-activator DHX9 interacted with p-p65, inducingNF-κB downstream genes expression. Conclusions: These findings suggest that SNORA42 is up-regulated in ESCC and promotes ESCC developments,partly via interacting with DHX9 and triggering SNORA42/DHX9/p65 axis.

Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex

A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS

A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence

Novel Cancer-Promoting Functions and Mechanisms for snoRNAs

SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter

Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations

Advances in the mechanism of small nucleolar RNA and its role in DNA damage response

A snoRNA-tRNA modification network governs codon-biased cellular states

Small but Strong: Pivotal Roles and Potential Applications of Snornas in Hematopoietic Malignancies

Noncoding RNA-chromatin Association: Functions and Mechanisms.

Conserved Composition of Mammalian Box H/ACA and Box C/D Small Nucleolar Ribonucleoprotein Particles and Their Interaction with the Common Factor Nopp140.

High-grade ovarian cancer associated H/ACA snoRNAs promote cancer cell proliferation and survival

SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer.

A Chromatin Localization Screen Reveals Poly (ADP Ribose)-Regulated Recruitment of the Repressive Polycomb and NuRD Complexes to Sites of DNA Damage.

SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9

C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1

The Snorna-Like Lncrna LNC-SNO49AB Drives Leukemia by Activating the RNA-editing Enzyme ADAR1

Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer

The small nucleolar RNA SNORA51 enhances breast cancer stem cell‐like properties via the RPL3/NPM1/c‐MYC pathway

Intronic small nucleolar RNAs regulate host gene splicing through base pairing with their adjacent intronic sequences

SNORA42 Promotes Oesophageal Squamous Cell Carcinoma Development Through Triggering the DHX9/p65 Axis